These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Lysine Demethylation in Pathogenesis. Cao J; Yan Q Adv Exp Med Biol; 2023; 1433():1-14. PubMed ID: 37751133 [TBL] [Abstract][Full Text] [Related]
5. Drug discovery of histone lysine demethylases (KDMs) inhibitors (progress from 2018 to present). He X; Zhang H; Zhang Y; Ye Y; Wang S; Bai R; Xie T; Ye XY Eur J Med Chem; 2022 Mar; 231():114143. PubMed ID: 35101649 [TBL] [Abstract][Full Text] [Related]
6. Targeting the LSD1/KDM1 Family of Lysine Demethylases in Cancer and Other Human Diseases. Mao F; Shi YG Adv Exp Med Biol; 2023; 1433():15-49. PubMed ID: 37751134 [TBL] [Abstract][Full Text] [Related]
7. The Emerging Role of Histone Demethylases in Renal Cell Carcinoma. Guo X; Zhang Q J Kidney Cancer VHL; 2017; 4(2):1-5. PubMed ID: 28725537 [TBL] [Abstract][Full Text] [Related]
9. The emerging role of histone lysine demethylases in prostate cancer. Crea F; Sun L; Mai A; Chiang YT; Farrar WL; Danesi R; Helgason CD Mol Cancer; 2012 Aug; 11():52. PubMed ID: 22867098 [TBL] [Abstract][Full Text] [Related]
10. The Emerging Significance of Histone Lysine Demethylases as Prognostic Markers and Therapeutic Targets in Head and Neck Cancers. Dorna D; Paluszczak J Cells; 2022 Mar; 11(6):. PubMed ID: 35326475 [TBL] [Abstract][Full Text] [Related]
11. The X-linked mental retardation gene SMCX/JARID1C defines a family of histone H3 lysine 4 demethylases. Iwase S; Lan F; Bayliss P; de la Torre-Ubieta L; Huarte M; Qi HH; Whetstine JR; Bonni A; Roberts TM; Shi Y Cell; 2007 Mar; 128(6):1077-88. PubMed ID: 17320160 [TBL] [Abstract][Full Text] [Related]
12. Disorders of histone methylation: Molecular basis and clinical syndromes. Al Ojaimi M; Banimortada BJ; Othman A; Riedhammer KM; Almannai M; El-Hattab AW Clin Genet; 2022 Sep; 102(3):169-181. PubMed ID: 35713103 [TBL] [Abstract][Full Text] [Related]
13. A scintillation proximity assay for histone demethylases. Yu W; Eram MS; Hajian T; Szykowska A; Burgess-Brown N; Vedadi M; Brown PJ Anal Biochem; 2014 Oct; 463():54-60. PubMed ID: 25010373 [TBL] [Abstract][Full Text] [Related]
14. The role of histone H3 lysine demethylases in glioblastoma. Young D; Guha C; Sidoli S Cancer Metastasis Rev; 2023 Jun; 42(2):445-454. PubMed ID: 37286866 [TBL] [Abstract][Full Text] [Related]
15. Jumonji histone demethylases as emerging therapeutic targets. Park SY; Park JW; Chun YS Pharmacol Res; 2016 Mar; 105():146-51. PubMed ID: 26816087 [TBL] [Abstract][Full Text] [Related]
16. Comprehensive analyses of prognostic biomarkers and immune infiltrates among histone lysine demethylases (KDMs) in hepatocellular carcinoma. Qu LH; Fang Q; Yin T; Yi HM; Mei GB; Hong ZZ; Qiu XB; Zhou R; Dong HF Cancer Immunol Immunother; 2022 Oct; 71(10):2449-2467. PubMed ID: 35254477 [TBL] [Abstract][Full Text] [Related]
17. [Expression pattern of the histone lysine demethylase family and its potential role in bladder cancer: a multi-omics analysis]. Fu X; Yu G; Guo Y Nan Fang Yi Ke Da Xue Xue Bao; 2022 Dec; 42(12):1822-1831. PubMed ID: 36651250 [TBL] [Abstract][Full Text] [Related]
18. The role and prospect of lysine-specific demethylases in cancer chemoresistance. Song YQ; Yang GJ; Ma DL; Wang W; Leung CH Med Res Rev; 2023 Sep; 43(5):1438-1469. PubMed ID: 37012609 [TBL] [Abstract][Full Text] [Related]
19. Histone Methylation Regulation in Neurodegenerative Disorders. Basavarajappa BS; Subbanna S Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925016 [TBL] [Abstract][Full Text] [Related]